mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.03 |
0.3 |
mRNA |
BRD-K70511574 |
CTRPv2 |
pan-cancer |
AAC |
0.03 |
0.3 |
mRNA |
BRD-K02492147 |
CTRPv2 |
pan-cancer |
AAC |
-0.038 |
0.3 |
mRNA |
AT7867 |
CTRPv2 |
pan-cancer |
AAC |
-0.033 |
0.4 |
mRNA |
procarbazine |
CTRPv2 |
pan-cancer |
AAC |
-0.036 |
0.4 |
mRNA |
BRD-K41334119 |
CTRPv2 |
pan-cancer |
AAC |
0.065 |
0.4 |
mRNA |
silmitasertib |
CTRPv2 |
pan-cancer |
AAC |
-0.036 |
0.4 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.03 |
0.4 |
mRNA |
Bortezomib |
gCSI |
pan-cancer |
AAC |
-0.056 |
0.4 |
mRNA |
BRD9647 |
CTRPv2 |
pan-cancer |
AAC |
0.034 |
0.4 |